Search Medical Condition
Please enter condition
Please choose location from dropdown

Oudenaarde, Belgium Clinical Trials

A listing of Oudenaarde, Belgium clinical trials actively recruiting patients volunteers.

RESULTS

Found (10) clinical trials

Task-oriented Upper Limb Training in MS

An adequate upper limb function is crucial to independently perform Activities of Daily Living (ADL). Persons with neurological diseases often experience upper limb dysfunction. Upper limb function in Multiple Sclerosis (MS) is highly prevalent, increasing with overall disability level, while the detrimental impact on ADL is higher than in stroke, ...

Phase

1.47 miles

Learn More »

A Prospective Evaluation of Natriuretic Peptide Based Referral of CHF Patients in Primary Care

In the majority of European countries, the primary management of chronic heart failure patients is performed by General Practitioners in collaboration with cardiologists (specialists). Previous studies have shown that many patients suffering from CHF do not receive optimal pharmacological and/or device treatment for their disease. An increase in natriuretic peptides ...

Phase

1.56 miles

Learn More »

A Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Non-diabetic Severely Obese Participants

The purpose of this study is to assess the effects of JNJ-64565111 compared with placebo after 26 weeks of treatment on the percent change in body weight from baseline and to assess the safety and tolerability, in non-diabetic severely obese participants.

Phase

6.46 miles

Learn More »

A Study to Assess the Impact of Sarcopenia on the Outcomes of Colorectal Cancer Patients Treated With Chemotherapy Combined With Bevacizumab

The purpose of this study is to explore the relationship between sarcopenia, as defined by computed tomography, treatment related outcomes and other body composition related parameters in a patient population receiving bevacizumab beyond progression.

Phase N/A

6.46 miles

Learn More »

Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND)

The purpose of this multi-center event-driven study in non-dialysis (ND) participants with anemia associated with chronic kidney disease (CKD) is to evaluate the safety and efficacy of daprodustat compared to darbepoetin alfa.

Phase

6.46 miles

Learn More »

International Pediatric Peritoneal Biopsy Study

Please see study protocol and http://www.pedpd.org http://4c-study.org

Phase N/A

6.58 miles

Learn More »

Belgian Central Sleep Apnea REgistry

Central sleep apnea (CSA) is characterized by intermittent cessation or decrease of airflow and effort of breathing during sleep. The diagnostic criteria for CSA varies according to the type of CSA (e.g. CSA due to cardiac failure, due to a medication, ...). CSA is defined as: (1) an apnea/hypopnea index ...

Phase N/A

6.66 miles

Learn More »

Comparison of Static Air Support Devices (Repose ) and Alternating-Pressure Devices in the Prevention of Pressure Ulcers

Maintaining and improving skin health are major goals in acute and long-term care. Patients at the extremes of age, the critically ill, medically compromised and those with immobility are at risk for developing several skin disorders, with pressure ulcers (PUs) as one of the most common and mostly preventable ones. ...

Phase N/A

8.25 miles

Learn More »

Silicone Adhesive Multilayer Foam Dressings to Prevent Pressure Ulcer

A multicentre randomised controlled open label parallel group medical device trial in approximately 8 hospitals in Belgium. Patients will be randomly allocated to three study arms based on a 1:1:1 allocation: Study arm 1 (on top of standard of care): Patients at risk for pressure ulcer category II, III, IV, ...

Phase N/A

8.61 miles

Learn More »

Peripheral Histamine 1 Receptor Blockade in IBS: Multicenter Trial

Purpose To evaluate the efficiency of Irritable Bowel Syndrome (IBS) patients treatment with the H1-receptor antagonist ebastine. Design Double blind randomized placebo controlled trial. IBS patients receive a 12-weeks treatment with ebastine 20mg once daily or placebo (1:1 randomization).

Phase

9.04 miles

Learn More »